Skip to main content
Equibles
XTNT logo

XTNT · Xtant Medical Holdings, Inc.

Track XTNT — free

Use XTNT with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about XTNT

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.31 -0.01 (-2.24%) At close · Aug 14
Market Cap
$42.79M
Shares
140.29M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.31 Open$0.30 Day$0.30–0.32 52W close$0.31–0.92 Avg vol 30d140K Short int89K · 0.1% float · 1.7d Short vol14% Last earningsAug 11, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 11

Up next

Next earnings call
Nov 9, 2026 Est · unconfirmed · in 12 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 11, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Strong Sell Momentum Very Weak Sentiment Bearish Fundamentals Excellent Quant / Vol Very High
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Strong Sell
      50 / 200-day cross No cross
      Price vs 200-day avg −46%
      below
      Price vs 50-day avg −28%
      below
      RSI (14) 21
      oversold
      MACD trend Negative
      52-week position 0%
      near low
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Weak
      1-month return −32%
      trailing
      6-month return −48%
      trailing
      YTD return −61%
      this year
      Relative strength −62%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bearish
      Trend (MA cross) No cross
      50d $0 › 200d $1 — 200d above 50d
      Institutional flow Distributing
      -9% holders QoQ · +5 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      0.06% of float · ▲ +27.0% MoM · 1.7 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      31 holders — mid 3-yr range
      Squeeze score 37
      low risk · 0–100
      Fundamentals
      Excellent
      Revenue growth −18%
      Y/Y
      Gross margin 158%
      expanding
      EPS growth +125%
      Y/Y
      Free cash flow $10.2M
      Balance sheet $6.0M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 61%
      annualized · 1-yr
      Max drawdown −67%
      past year
      ATR 10.9%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Aug 11, 2026
      Full-year revenue · full year 2026 Initiated $99M – $103M
      prior FY $133.93M midpoint −24.6% Y/Y
      Prior guidance period ended · from the 8-K filed Nov 10, 2025
      Full-year 2025 revenue · full-year 2025 $131M – $135M
      Guided vs delivered · last 1 settled
      Full-year 2025 revenue full-year 2025
      guided $131M – $135M
      $133.93M In line

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Strong Sell
      4 · 3 · 0
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −46% Bearish
      Price vs 50-day avg
      −28% Bearish
      RSI (14)
      21 Neutral
      MACD trend
      Negative Bearish
      52-week position
      0% Bearish
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bearish · 2 of 6
      Trend (MA cross) No cross
      50d $0 › 200d $1 — 200d above 50d
      Institutional flow Distributing
      -9% holders QoQ · +5 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      0.06% of float · ▲ +27.0% MoM · 1.7 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      31 holders — mid 3-yr range
      Price context
      position in its 52-week range
      Range low $0 Now $0 · 0% Range high $1
      vs 200-day avg -46% vs 50-day avg -28%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Medical Devices — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      XTNT
      Xtant Medical Holdings, Inc.
      this stock
      		$42.79M -60.9% -17.5% — 0.1%
      ABT
      Abbott Laboratories
      		 $193.78B -11.2% +5.7% 31.2 1.3%
      SYK
      Stryker Corp
      		 $130.11B -3.5% +11.2% 35.2 2.2%
      MDT
      Medtronic plc
      		 $116.83B -5.0% +8.4% 24.5 1.4%
      BSX
      Boston Scientific Corp
      		 $75.11B -45.6% +12.5% 21.0 1.5%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Reducing
      Holders
      31
      % held
      57.2%
      Net QoQ
      -495.3K sh
      Top holder
      Nantahala Capital Managem…
      Held Float
      View
      Held by Funds
      Fund positions
      6
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      89.0K
      Days to cover
      1.7d
      Change
      +18.9K sh
      View
      Short Volume
      Short vol %
      14%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      44
      Value
      $18
      As of
      Jul 6, 2026
      View
      Off-Exchange
      Off-exchange %
      52.0%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Financials
      Financials
      Revenue (FY)
      $133.9M
      Net income (FY)
      $5.0M
      EPS diluted
      $0.03
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 11, 2026
      This year
      11
      View
      Exempt Offerings
      Offering
      $5.0M
      Filed
      Aug 12, 2024
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 11, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      XTNT -31.3% -32.2% -48.3% -29.0% -60.9%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY -31.7% -36.7% -62.1% -33.0% -74.8%
      Key facts CIK 1453593 CUSIP 98420P308 13F (30d) 30 filings 30 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)